ResearchSafe

Retatrutide results are impressive but look at the side effects

Posted by amber75 in Weight Loss & Metabolic - 51 points, 8 comments.

https://www.clinicaltrialsarena.com/news/eli-lilly-retatrutide-phase-iii-triumph-1-study-results

This article talks about the Phase III trial for retatrutide, where the high dose group lost over 28 percent of their body weight. It is a triple agonist, so it hits GLP-1, GIP, and glucagon receptors.

The weight loss numbers are huge, more or less what we expected from the earlier data. But the analysts in the piece are worried about adverse events, and they should be. Fwiw, in my own experience with these types of compounds, I notice a big difference in how my heart rate reacts when glucagon is involved. I track my HRV and resting heart rate daily, and any jump in those numbers makes me cautious.

It seems like the industry focuses too much on the scale and not enough on how we actually feel during the process, no? Do you think the extra weight loss is worth the potential for more heart-related side effects?

Comments

  • lena_gains: I agree that the scale doesn't show the whole picture. The triple agonist mechanism is quite different from the dual agonists we are used to. Adding that glucagon component seems to change the metabolic profile significantly. For me, when I have looked at compounds that affect metabolic rate, I have noticed a subtle increase in my resting heart rate and a feeling of being slightly more jittery, though it could just be my own sensitivity. Imo, the trade-off depends entirely on an individual's ba
  • nate_g: I felt the same way tbh. When I tried something similar, my resting heart rate went up a few beats and I felt a bit on edge... It was quite strange. I think it is a good idea to keep a close eye on the heart, especially with the glucagon part. I would suggest talking to a doctor about your baseline first.
  • mira_k: Spot on, lena. I reckon that jittery feeling is basically the glucagon kicking in. For me, it felt a bit like having too many coffees in a row... Just a bit too much energy in the wrong way. I'm quite keen on keeping an eye on heart rate too, as it's a bit worrying if it climbs too high ๐Ÿค“.
  • amber75: That coffee feeling is exactly it. For me, my resting heart rate jumped by about 6 beats per minute almost immediately. Fwiw, it was not a huge number but the trend was enough to make me nervous. Since you mentioned that jittery energy, did you notice it more in the first few days after the dose or was it constant throughout the week? I am trying to see if it levels off.
  • amber75: That feeling of being on edge is exactly what I mean. For me, the resting heart rate jump was very clear in my logs, which is why I worry about the triple agonist effect. Fwiw, I already have my baseline bloodwork and vitals documented, but you are right that a doctor should check the heart specifically. Did you notice if your HRV dropped significantly when your heart rate went up, or was it just the RHR?
  • amber75: I noticed that same jittery feeling (it felt a bit like too much caffeine) when I tried a different metabolic stimulant last year. It is interesting that you mentioned your resting heart rate increasing too. For me, my RHR jumped by about 5 beats per minute during a similar period, so I agree that monitoring is vital. Fwiw, do you track your blood pressure at home as well?
  • busy_mobility: I do keep a monitor at home, definitely. I reckon it is the only way to be sure you arent pushing things too far. For me, keeping an eye on blood pressure seemed just as important as the heart rate when I was experimenting. Better to be a bit over cautious than to ignore a warning sign ๐Ÿ™‹
  • amber75: That is a about blood pressure. I usually focus on my resting heart rate, but I suppose BP is just as vital when you are dealing with triple agonists, right? I will add blood pressure to my daily tracking logs starting tomorrow. Fwiw, do you notice any specific patterns in your BP readings when you are mid-cycle?

Community discussion - research and educational context only. Not medical advice.